- Home
- DY vs GH Comparison
DY vs GH Comparison
Compare DY & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DY
- GH
- Stock Information
- Founded
- DY 1969
- GH 2011
- Country
- DY United States
- GH United States
- Employees
- DY N/A
- GH N/A
- Industry
- DY Water Sewer Pipeline Comm & Power Line Construction
- GH Medical Specialities
- Sector
- DY Industrials
- GH Health Care
- Exchange
- DY Nasdaq
- GH Nasdaq
- Market Cap
- DY 5.3B
- GH 5.5B
- IPO Year
- DY N/A
- GH 2018
- Fundamental
- Price
- DY $229.76
- GH $40.62
- Analyst Decision
- DY Strong Buy
- GH Strong Buy
- Analyst Count
- DY 10
- GH 21
- Target Price
- DY $233.10
- GH $52.81
- AVG Volume (30 Days)
- DY 463.1K
- GH 2.3M
- Earning Date
- DY 05-21-2025
- GH 04-30-2025
- Dividend Yield
- DY N/A
- GH N/A
- EPS Growth
- DY 1.66
- GH N/A
- EPS
- DY 7.89
- GH N/A
- Revenue
- DY $4,818,199,000.00
- GH $773,996,000.00
- Revenue This Year
- DY $14.72
- GH $23.05
- Revenue Next Year
- DY $7.99
- GH $21.40
- P/E Ratio
- DY $29.15
- GH N/A
- Revenue Growth
- DY 12.77
- GH 28.20
- 52 Week Low
- DY $131.37
- GH $20.14
- 52 Week High
- DY $230.57
- GH $52.92
- Technical
- Relative Strength Index (RSI)
- DY 86.66
- GH 48.45
- Support Level
- DY $186.42
- GH $37.73
- Resistance Level
- DY $228.45
- GH $39.63
- Average True Range (ATR)
- DY 6.38
- GH 1.60
- MACD
- DY 2.43
- GH -0.01
- Stochastic Oscillator
- DY 98.18
- GH 60.00
About DY Dycom Industries Inc.
Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. Its operating companies supply telecommunications providers with a comprehensive portfolio of specialty services, including program management; planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services and provide underground facility locating services for various utilities, including telecommunications providers, and others. It also provides a range of construction, maintenance, and installation services, including the placement and splicing of fiber, copper, and coaxial cables. It provides services throughout the United States.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.